Swedish Orphan Biovitrum (Sweden)
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Swedish Orphan Biovitrum (Sweden), Sweden, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
52%
Total
Publications
635
Total Open
Publications
333
Total
Citations
19K
Open Access
Percentage
52%
Total
Publications
635
Total Open
Publications
333
Total
Citations
19K
Breakdown
Publisher Open
22%
Both
26%
Other Platform Open
4%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 43%
129
Hybrid 29%
88
No Guarantees 28%
83
Other Platform Open
Domain 72%
138
Institution 35%
68
Other Internet 16%
30
Preprint 2%
4
Public 2%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 138 |
University College of Arts Crafts and Design | Institution | 31 |
DOI | Other Internet | 29 |
Europe PMC | Domain | 11 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 8 |
University of Milan | Institution | 5 |
Royal Netherlands Academy of Arts and Sciences | Institution | 4 |
Harris County Public Library | Institution | 4 |
Figshare | Public | 4 |
University of Michigan–Ann Arbor | Institution | 3 |